000 02872nam a2200253Ia 4500
003 MX-MdCICY
005 20250625160151.0
040 _cCICY
090 _aB-16427
245 1 0 _aOptimization and partial characterization of intracellular anticandidal protein from Aspergillus giganteus MTCC 8408 using taguchi DOE
490 0 _vBioengineered, 14 January, p.1-13, 2017
520 3 _aA new intracellular antifungal protein (afp)production with average molecular weight 24.3 kDa and yield of 0.65 ± 0.1 mg/gram dry cell weight (gdcw)of mycelia in submerged fermentation of Aspergillusgiganteus MTCC 8408 was optimized. Taguchi's DOE (design of experiment)L27 orthogonal array (OA)was constructed using Qualitek-4 software with 8 most influensive factors namely, culture pH, temperature, slant age, inoculum volume, agitation and KH2PO4. Scanning electron microscopy (SEM)was used to correlate the effect of selected factors on fungal cell morphology and afp production. The crude protein purification was accomplished using pure ammonium sulfate fractionation followed by carboxymethyl cellulose (CMC)ion-exchange chromatography and sephadex G-100 gel filtration. The average molecular mass of the purified protein was figured by silver stained SDS (sodium dodecylsulphate)-PAGE (poly-acryl amide gel electrophoresis). In vitro antifungal susceptibility assay was profiled against Candida albicans NCIM 3471 and minimum inhibitory concentrations (MICs)were in the range 3 to 4 µg/ml. Characterization of protein was observed with FTIR (Fourier transform infrared spectroscopy)analysis. The optimal production condition for crude afp was obtained as follows: soluble starch: 20 g/l; Corn steep liquor (CSL, 2 per cent)+ proteose peptone (PP, 1 per cent): 30 g/l; pH: 5.8; temperature: 25°C; slant age: 3 d; inoculum size: 5 per cent (v/v); agitation: 180 rpm; KH2PO4: 0.1 g/l. The validation experiments using optimized conditions confirmed an improvement in afp production by 59.4 per cent against the expected enhancement of afp production by 61.22 per cent. The present statistical optimization study revealed an opportunity to promote economical design at the industrial level for future scale up of effective antifungal agent against opportunistic oral and vaginal infection. © 2017 Taylor & Francis
650 1 4 _aANTIFUNGAL PROTEIN (AFP)
650 1 4 _aASPERGILLUS GIGANTEUS MTCC: 8408
650 1 4 _aCANDIDA ALBICANS NCIM 3471
650 1 4 _aCHARACTERIZATION
650 1 4 _aMINIMUM INHIBITORY CONCENTRATION (MIC)
650 1 4 _aTAGUCHI (DOE)L27 ORTHOGONAL ARRAY (OA)
700 1 2 _aDutta, D.
700 1 2 _aDas, M.D.
856 4 0 _uhttps://drive.google.com/file/d/1Kmz8rmcHGoyTzxE8flz9il6VqlmUDN8S/view?usp=drivesdk
_zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942 _2Loc
_cREF1
008 250602s9999 xx |||||s2 |||| ||und|d
999 _c50601
_d50601